Evidence map›Paper›PMID 30483575›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2018

Antifibrogenic effect of melatonin in rats with experimental liver cirrhosis induced by carbon tetrachloride.

Silvia Bona, Graziella Rodrigues, Andrea J Moreira, Fábio C Di Naso, Alexandre S Dias, Thêmis R Da Silveira, Claudio A Marroni, Norma P Marroni

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. [Melatonin reverses oxidative damage in the submandibular gland of rats treated with Cyclophosphamide].Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Protective role of melatonin in early-stage and end-stage liver cirrhosis.Journal of cellular and molecular medicine · 2019
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Silvia BonaCenter of Experimental Research Hospital de Clínicas de Porto Alegre Porto Alegre RS Brazil.ORCID 0000-0003-4431-440X
Graziella RodriguesCenter of Experimental Research Hospital de Clínicas de Porto Alegre Porto Alegre RS Brazil.
Andrea J MoreiraCenter of Experimental Research Hospital de Clínicas de Porto Alegre Porto Alegre RS Brazil.
Fábio C Di NasoCenter of Experimental Research Hospital de Clínicas de Porto Alegre Porto Alegre RS Brazil.
Alexandre S DiasPostgraduate Program in Pneumological Sciences Universidade Federal do Rio Grande do Sul Porto Alegre RS Brazil.
Thêmis R Da SilveiraCenter of Experimental Research Hospital de Clínicas de Porto Alegre Porto Alegre RS Brazil.
Claudio A MarroniCenter of Experimental Research Hospital de Clínicas de Porto Alegre Porto Alegre RS Brazil.
Norma P MarroniCenter of Experimental Research Hospital de Clínicas de Porto Alegre Porto Alegre RS Brazil.
Universidade Federal do Rio Grande do Sul · BRHospital de Clínicas de Porto Alegre · BRUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimLiver diseases are a major public health problem, accounting for a significant number of hospital visits and admissions and an increasing mortality rate. Melatonin (MLT) is a powerful antioxidant molecule that has been shown to be beneficial under various conditions. The objective was to evaluate the effect of MLT on experimental liver cirrhosis induced by carbon tetrachloride (CCl

methodsTwenty male Wistar rats (230-250 g) were divided into four groups. I: control group (CO); II: CO + MLT; III: CCl

resultsIn the CCl

conclusionMLT has a potent antifibrogenic effect, modulating the parameters of oxidative stress, angiogenesis, and inflammation.

Indexed as

antioxidantsmelatonin and liver cirrhosisoxidative damage

Identifiers

PMID30483575
PMCPMC6206983
OpenAlexW2804020734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.